脑室内纤溶联合腰大池引流预防严重脑室受累脑出血后永久分流依赖的随机试验与个体患者数据Meta分析
该随机开放标签平行组试验纳入18-85岁、院前mRS≤3、血肿<60ml、GCS<9且严重脑室内出血需EVD的患者,比较脑室内纤溶(IVF)联合腰大池引流(LD)与单用IVF对永久分流依赖的影响。因干预显著有效,30例后提前终止:主要终点对照组43%(7/16) vs 干预组0%(0/14)(p=0.007)。个体患者数据Meta分析(97例)显示分流依赖绝对风险降低24%(LD 2.2% vs 无LD 26.2%;OR=0.062,95%CI 0.011-0.361;p=0.002),出血并发症显著减少(OR=0.401,95%CI 0.302-0.532;p<0.001)。
要点
- 严重脑室内出血患者,IVF联合LD较单用IVF显著降低永久分流依赖(0% vs 43%,p=0.007)。
- Meta分析示分流依赖绝对风险降低24%(OR=0.062,95%CI 0.011-0.361)。
- 联合治疗出血并发症显著减少(OR=0.401,95%CI 0.302-0.532),脑脊液感染无显著差异。
核心结论
- 在严重脑室内出血患者中,IVF联合LD治疗可行且安全,较单用IVF显著降低脑出血后吸收性脑积水的永久分流依赖率。
研究设计与样本
- 随机、开放标签、平行组试验,纳入18-85岁、院前mRS≤3、血肿<60ml、GCS<9、严重IVH伴第三和第四脑室填塞需EVD的患者,因预设中期分析显示干预显著有效,30例后提前终止;并进行了个体患者数据Meta分析(共97例,45例接受IVF+LD,42例单用IVF)。
主要发现
- 主要终点(永久分流依赖)在对照组为43%(7/16),干预组为0%(0/14),p=0.007。
- Meta分析显示分流依赖绝对风险降低24%(LD组2.2%[1/45] vs 无LD组26.2%[11/42];OR=0.062;95%CI 0.011-0.361;p=0.002)。
- 脑脊液感染无显著差异(OR=0.869;95%CI 0.445-1.695;p=0.680)。
- 90天功能结局无显著差异(OR=0.478;95%CI 0.190-1.201;p=0.116)。
- 出血并发症显著减少,利于干预组(OR=0.401;95%CI 0.302-0.532;p<0.001)。
关键数值与推荐
- IVF方案:重组人组织型纤溶酶原激活剂1mg,每8小时一次,直至第三和第四脑室血凝块清除。
- 主要终点定义:三次EVD夹闭尝试失败后指示永久分流放置,或需要脑脊液引流超过14天。
临床怎么用
- 对于严重脑室内出血需EVD的患者,可考虑IVF联合LD以降低永久分流依赖风险。
- 联合治疗未增加脑脊液感染风险,且出血并发症更少,支持其安全性。
- 功能结局未见显著改善,治疗决策需结合个体情况。
局限性
- 试验因中期分析显示显著疗效而提前终止,样本量小(30例)。
- 开放标签设计可能引入偏倚。
- Meta分析基于个体患者数据,但总体样本量仍有限(97例)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Intraventricular hemorrhage (IVH) is a negative prognostic factor in intracerebral hemorrhage (ICH) and is associated with permanent shunt dependency in a substantial proportion of patients post-ICH. IVH treatment by intraventricular fibrinolysis (IVF) was recently linked to reduced mortality rates in the CLEAR III study and IVF represents a safe and effective strategy to hasten clot resolution that may reduce shunt rates. Additionally, promising results from observational studies reported reductions in shunt dependency for a combined treatment approach of IVF plus lumbar drains (LDs). The present randomized, controlled trial investigated efficacy and safety of a combined strategy-IVF plus LD versus IVF alone-on shunt dependency in patients with ICH and severe IVH. METHODS: This randomized, open-label, parallel-group study included patients aged 18 to 85 years, prehospital modified Rankin Scale ≤3, ICH volume < 60ml, Glasgow Coma Scale of <9, and severe IVH with tamponade of the third and fourth ventricles requiring placement of external ventricular drainage (EVD). Over a 3-year recruitment period, patients were allocated to either standard treatment (control group receiving IVF consisting of 1mg of recombinant human tissue plasminogen activator every 8 hours until clot clearance of third and fourth ventricles) or a combined treatment approach of IVF and-upon clot clearance of third and fourth ventricles-subsequent placement of an LD for drainage of cerebrospinal fluid (CSF; intervention group). The primary endpoint consisted of permanent shunt placement indicated after a total of three unsuccessful EVD clamping attempts or need for CSF drainage longer than 14 days in both groups. Secondary endpoints included IVF- and LD-related safety, such as bleeding or infections, and functional outcome at 90 and 180 days. Conducted endpoint analyses used individual patient data meta-analyses. The study was registered at clinicaltrials.gov (NCT01041950). RESULTS: The trial was stopped upon predefined interim analysis after 30 patients because of significant efficacy of tested intervention. The primary endpoint was analyzed without dropouts and was reached in 43% (7 of 16) of the control group versus 0% (0 of 14) of the intervention group (p = 0.007). Meta-analyses were based on overall 97 patients, 45 patients receiving IVF plus LD versus 42 with IVF only. Meta-analyses on shunt dependency showed an absolute risk reduction of 24% for the intervention (LD, 2.2% [1 of 45] vs no-LD, 26.2% [11 of 42]; odds ratio [OR] = 0.062; confidence interval [CI], 0.011-0.361; p = 0.002). Secondary endpoints did not show significant differences for CSF infections (OR = 0.869;CI, 0.445-1.695; p = 0.680) and functional outcome at 90 days (OR = 0.478; CI, 0.190-1.201; p = 0.116), yet bleeding complications were significantly reduced in favor of the intervention (OR = 0.401; CI, 0.302-0.532; p < 0.001). INTERPRETATION: The present trial and individual patient data meta-analyses provide evidence that, in patients with severe IVH, as compared to IVF alone, a combined approach of IVF plus LD treatment is feasible and safe and significantly reduces rates of permanent shunt dependency for aresorptive hydrocephalus post-ICH. ANN NEUROL 2017;81:93-103.
引用
- Staykov D, Kuramatsu JB, Bardutzky J, et al. Efficacy and safety of combined intraventricular fibrinolysis with lumbar drainage for prevention of permanent shunt dependency after intracerebral hemorrhage with severe ventricular involvement: A randomized trial and individual patient data meta-analysis. Ann Neurol. 2017. PMID: 27888608. doi:10.1002/ana.24834
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。